Replies to post #209719 on Biotech Values

[WorstLuck]

I tend to agree with that and it is part of my investment thesis.

The more important question right now might be what the market thinks of that. I don't have a good feel for that right now, although I have seen duration mentioned as a reason to buy. Right or wrong my position size right now is fairly conservative, where it had been strongly overweighted around $13 dollars.

[jbog]

I agree in most part. The hurdle that Revance will face solely lies in prying Allergans grip on the dispensing doctors.

That will be a tall order.